SCHEMBL17824797

SCHEMBL17824797

Cc1cc(CN2C(=O)c3cccc4cccc(c34)C2=O)on1

nearest known ligand 0.77

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 1/20 0.63
KDM4E B2RXH2 6/20 0.57
ALDH1A1 P00352 2/20 0.57
CYP1B1 Q16678 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
MAPT P10636 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
RECQL P46063 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
HTT P42858 1/20 0.49
UBE2N P61088 1/20 0.48
ATM Q13315 1/20 0.48
HEXA P06865 4/20 0.48
HEXB P07686 4/20 0.48
OGA O60502 1/20 0.48
GAA P10253 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17824939 0.79 PARG (1.00) PARG
SCHEMBL4094368 0.73 ALDH1A1 (1.00) KDM4EALDH1A1CYP1B1NPSR1MAPT
SCHEMBL117049 0.69 CYP1B1 (1.00) KDM4EALDH1A1CYP1B1NPSR1MAPT
SCHEMBL10262751 0.69 CYP1B1 (0.71) KDM4EALDH1A1CYP1B1NPSR1MAPT
SCHEMBL5594225 0.68 NPSR1 (1.00) KDM4EALDH1A1CYP1B1NPSR1MAPT
SCHEMBL8913973 0.67 MEN1 (0.54) ALDH1A1MAPTSMN1; SMN2RECQLCYP1A2
SCHEMBL1101932 0.66 CYP1B1 (0.73) KDM4EALDH1A1CYP1B1NPSR1MAPT
SCHEMBL29486056 0.66 CYP1B1 (0.73) KDM4EALDH1A1CYP1B1NPSR1MAPT
SCHEMBL28737148 0.66 UBE2N (0.82) KDM4EALDH1A1CYP1B1NPSR1MAPT
SCHEMBL4095117 0.66 ALDH1A1 (0.77) KDM4EALDH1A1CYP1B1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230273-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG Cancer Research Technology Ltd (GB) 2017-10-18 EP disclosed
WO-2016092326-A1 2,4-DIOXO-QUINAZOLINE-6-SULFONAMIDE DERIVATIVES AS INHIBITORS OF PARG CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-16 WO disclosed